Extracellular vesicle proteins associated with systemic vascular events correlate with heart failure: An observational study in a dyspnoea cohort

PLoS ONE

Volumn 11, Issue 1, 2016, Pages

  Zhang, Ya Nan ^a,b   Vernooij, Flora ^a,b   Ibrahim, Irwani ^c   Ooi, Shirley ^c   Gijsberts, Crystel M ^a,d   Schoneveld, Arjan H ^d   Sen, Kuan Win ^c   Den Ruijter, Hester M ^d   Timmers, Leo ^d,e   Richards, Arthur Mark ^b,f   Jong, Chun Tzen ^a,b   Mazlan, Ibrahim ^a,b   Wang, Jiong Wei ^a,b   Lam, Carolyn S P ^g   De Kleijn, Dominique P V ^a,b,d,e  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b DEPARTMENT OF CARDIOLOGY   (Singapore)

^c NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e INTERUNIVERSITY CARDIOLOGY INSTITUTE OF THE NETHERLANDS   (Netherlands)

^f UNIVERSITY OF OTAGO   (New Zealand)

^g NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; CD14 ANTIGEN; CELL PROTEIN; CYSTATIN C; EXTRACELLULAR VESICLE PROTEIN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; SERPIN F2; SERPIN G1; UNCLASSIFIED DRUG; ALPHA 2 ANTIPLASMIN; COMPLEMENT COMPONENT C1S INHIBITOR; SERPINF2 PROTEIN, HUMAN; SERPING1 PROTEIN, HUMAN;

ACUTE HEART FAILURE; ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DYSPNEA; EXOSOME; FEMALE; HEART FAILURE; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART FAILURE WITH REDUCED EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBSERVATIONAL STUDY; PROTEIN ANALYSIS; PROTEIN FUNCTION; SYSTEMIC VASCULAR EVENT; VASCULAR DISEASE; ACUTE DISEASE; AGED; BLOOD; PATHOLOGY;

ACUTE DISEASE; ADULT; AGED; ALPHA-2-ANTIPLASMIN; ANTIGENS, CD14; COMPLEMENT C1 INACTIVATOR PROTEINS; CROSS-SECTIONAL STUDIES; CYSTATIN C; EXTRACELLULAR VESICLES; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED;

EID: 84958212226     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0148073     Document Type: Article

References (52)

1. Colombo M, Raposo G, Thery C. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol. 2014;30:255-89. doi: 10.1146/annurev-cellbio-101512-122326 PMID: 25288114.
2. Zhang J, Hawari FI, Shamburek RD, Adamik B, Kaler M, Islam A, et al. Circulating TNFR1 exosomelike vesicles partition with the LDL fraction of human plasma. Biochem Biophys Res Commun. 2008;366(2):579-84. doi: 10.1016/j.bbrc.2007.12.011 PMID: 18078813; PubMed Central PMCID: PMCPMC2254504.
3. Wang JW, Gijsberts CM, Seneviratna A, de Hoog VC, Vrijenhoek JE, Schoneveld AH, et al. Plasma extracellular vesicle protein content for diagnosis and prognosis of global cardiovascular disease. Neth Heart J. 2013;21(10):467-71. doi: 10.1007/s12471-013-0462-3 PMID: 23975618; PubMed Central PMCID: PMCPMC3776081.
4. Sinning JM, Losch J, Walenta K, Bohm M, Nickenig G, Werner N. Circulating CD31+/Annexin V+ microparticles correlate with cardiovascular outcomes. Eur Heart J. 2011;32(16):2034-41. doi: 10.1093/eurheartj/ehq478 PMID: 21186238.
5. Nozaki T, Sugiyama S, Koga H, Sugamura K, Ohba K, Matsuzawa Y, et al. Significance of a Multiple Biomarkers Strategy Including Endothelial Dysfunction to Improve Risk Stratification for Cardiovascular Events in Patients at High Risk for Coronary Heart Disease. Journal of the American College of Cardiology. 2009;54(7):601-8. doi: 10.1016/j.jacc.2009.05.022 WOS:000268761100003. PMID: 19660689
6. Amabile N, Cheng S, Renard JM, Larson MG, Ghorbani A, McCabe E, et al. Association of circulating endothelial microparticles with cardiometabolic risk factors in the Framingham Heart Study. Eur Heart J. 2014;35(42):2972-9. doi: 10.1093/eurheartj/ehu153 PMID: 24742886; PubMed Central PMCID: PMCPMC4223610.
7. Nozaki T, Sugiyama S, Sugamura K, Ohba K, Matsuzawa Y, Konishi M, et al. Prognostic value of endothelial microparticles in patients with heart failure. Eur J Heart Fail. 2010;12(11):1223-8. doi: 10.1093/eurjhf/hfq145 PMID: 20817695.
8. Berezin AE, Kremzer AA, Samura TA, Martovitskaya YV. Circulating endothelial-derived apoptotic microparticles in the patients with ischemic symptomatic chronic heart failure: relevance of pro-inflammatory activation and outcomes. Int Cardiovasc Res J. 2014;8(3):116-23. PMID: 25177675; PubMed Central PMCID: PMCPMC4109036.
9. Kanhai DA, Visseren FL, van der Graaf Y, Schoneveld AH, Catanzariti LM, Timmers L, et al. Microvesicle protein levels are associated with increased risk for future vascular events and mortality in patients with clinically manifest vascular disease. Int J Cardiol. 2013;168(3):2358-63. doi: 10.1016/j.ijcard. 2013.01.231 PMID: 23484740.
10. Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. American Journal of Kidney Diseases. 2002;40(2):221-6. PMID: 12148093
11. de Hoog VC, Timmers L, Schoneveld AH, Wang JW, van de Weg SM, Sze SK, et al. Serum extracellular vesicle protein levels are associated with acute coronary syndrome. Eur Heart J Acute Cardiovasc Care. 2013;2(1):53-60. doi: 10.1177/2048872612471212 PMID: 24062934; PubMed Central PMCID: PMCPMC3760575.
12. Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. New England Journal of Medicine. 2005;352(20):2049-60. doi: 10.1056/NEJMoa043161 WOS:000229180100003. PMID: 15901858
13. Davis AE 3rd, Lu F, Mejia P. C1 inhibitor, a multi-functional serine protease inhibitor. Thromb Haemost. 2010;104(5):886-93. doi: 10.1160/TH10-01-0073 PMID: 20806108.
14. Schuliga M. The inflammatory actions of coagulant and fibrinolytic proteases in disease. Mediators Inflamm. 2015;2015:437695. doi: 10.1155/2015/437695 PMID: 25878399; PubMed Central PMCID: PMCPMC4387953.
15. Aharon A, Tamari T, Brenner B. Monocyte-derived microparticles and exosomes induce procoagulant and apoptotic effects on endothelial cells. Thromb Haemost. 2008;100(5):878-85. PMID: 18989533.
16. Lam CSP, Lyass A, Kraigher-Krainer E, Massaro JM, Lee DS, Ho JE, et al. Cardiac dysfunction and noncardiac dysfunction as precursors of heart failure with reduced and preserved ejection fraction in the community. Circulation. 2011;124(1):24-30. doi: 10.1161/CIRCULATIONAHA.110.979203 PMID: 21670229
17. Fox KF, Cowie MR, Wood DA, Coats AJS, Gibbs JSR, Underwood SR, et al. Coronary artery disease as the cause of incident heart failure in the population. European Heart Journal. 2001;22(3):228-36. doi: 10.1053/euhj.2000.2289 WOS:000166748500010. PMID: 11161934
18. Anker SD, von Haehling S. Inflammatory mediators in chronic heart failure: an overview. Heart. 2004;90(4):464-70. PMID: 15020532; PubMed Central PMCID: PMCPMC1768165.
19. Timmers L, van Keulen JK, Hoefer IE, Meijs MF, van Middelaar B, den Ouden K, et al. Targeted deletion of nuclear factor kappaB p50 enhances cardiac remodeling and dysfunction following myocardial infarction. Circ Res. 2009;104(5):699-706. doi: 10.1161/CIRCRESAHA.108.189746 PMID: 19168865.
20. Timmers L, Sluijter JP, van Keulen JK, Hoefer IE, Nederhoff MG, Goumans MJ, et al. Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction. Circ Res. 2008;102(2):257-64. doi: 10.1161/CIRCRESAHA.107.158220 PMID: 18007026.
21. Arslan F, de Kleijn DP, Pasterkamp G. Innate immune signaling in cardiac ischemia. Nat Rev Cardiol. 2011 May; 8(5):292-300. doi: 10.1038/nrcardio.2011.38
22. Paulus WJ, Tschope C. A Novel Paradigm for Heart Failure With Preserved Ejection Fraction Comorbidities Drive Myocardial Dysfunction and Remodeling Through Coronary Microvascular Endothelial Inflammation. Journal of the American College of Cardiology. 2013;62(4):263-71. WOS:000322064100002. PMID: 23684677
23. McMurray JJV, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. European Journal of Heart Failure. 2012;14(8):803-69. doi: 10.1093/eurjhf/hfs105 PMID: 22828712
24. Grodin JL, Neale S, Wu Y, Hazen SL, Tang WH. Prognostic comparison of different sensitivity cardiac troponin assays in stable heart failure. Am J Med. 2015;128(3):276-82. doi: 10.1016/j.amjmed.2014. 09.029 PMID: 25447612; PubMed Central PMCID: PMCPMC4340722.
25. Organization WH. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. 2011.
26. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions, (1970).
27. Lotvall J, Hill AF, Hochberg F, Buzas EI, Di Vizio D, Gardiner C, et al. Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles. J Extracell Vesicles. 2014;3:26913. doi: 10.3402/jev. v3.26913 PMID: 25536934; PubMed Central PMCID: PMCPMC4275645.
28. Allaire J, editor RStudio: Integrated Development Environment for R. The R User Conference, useR! 2011. August 16-18 2011 University of Warwick, Coventry, UK; 2011.
29. Team RC. R: A language and environment for statistical computing [Internet]. Vienna, Austria: R Foundation for Statistical Computing; 2013. Available: http://www.r-project.org. 2015.
30. Tschöpe C, Lam CSP. Diastolic heart failure: What we still don't know. Looking for new concepts, diagnostic approaches, and the role of comorbidities. Herz. 2012;37(8):875-9. doi: 10.1007/s00059-012-3719-5 PMID: 23179053
31. Richards M, Di Somma S, Mueller C, Nowak R, Peacock WF, Ponikowski P, et al. Atrial fibrillation impairs the diagnostic performance of cardiac natriuretic peptides in dyspneic patients: results from the BACH Study (Biomarkers in ACute Heart Failure). JACC Heart Fail. 2013;1(3):192-9. PMID: 24621869.
32. Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002 Jul. 18;347(3):161-7. PMID: 12124404
33. Travaglino F, Russo V, De Berardinis B, Numeroso F, Catania P, Cervellin G, et al. Thirty and ninety days mortality predictive value of admission and in-hospital procalcitonin and mid-regional pro-adrenomedullin testing in patients with dyspnea. Results from the VERyfing DYspnea trial. Am J Emerg Med. 2014;32(4):334-41. doi: 10.1016/j.ajem.2013.12.045 PMID: 24559907.
34. Yeo TJ, Yeo PSD, Ching-Chiew Wong R, Ong HY, Leong KTG, Jaufeerally F, et al. Iron deficiency in a multi-ethnic Asian population with and without heart failure: prevalence, clinical correlates, functional significance and prognosis. European journal of heart failure. 2014;16(10):1125-32. doi: 10.1002/ejhf. 161 PMID: 25208495
35. Gijsberts CM, Seneviratna A, de Carvalho LP, den Ruijter HM, Vidanapthirana P, Sorokin V, et al. Ethnicity Modifies Associations between Cardiovascular Risk Factors and Disease Severity in Parallel Dutch and Singapore Coronary Cohorts. Plos One. 2015;10(7):e0132278. ARTN e0132278 doi: 10. 1371/journal.pone.0132278 WOS:000358157600230. PMID: 26147693
36. Shah RV, McNulty S, O'Connor CM, Felker GM, Braunwald E, Givertz MM. Effect of admission oral diuretic dose on response to continuous versus bolus intravenous diuretics in acute heart failure: an analysis from diuretic optimization strategies in acute heart failure. Am Heart J. 2012;164(6):862-8. doi: 10.1016/j.ahj.2012.08.019 PMID: 23194486; PubMed Central PMCID: PMCPMC3909675.
37. Lonez C, Irvine KL, Pizzuto M, Schmidt BI, Gay NJ, Ruysschaert JM, et al. Critical residues involved in Toll-like receptor 4 activation by cationic lipid nanocarriers are not located at the lipopolysaccharidebinding interface. Cell Mol Life Sci. 2015;72(20):3971-82. doi: 10.1007/s00018-015-1915-1 PMID: 25956320; PubMed Central PMCID: PMCPMC4575701.
38. Arslan F, de Kleijn DP, Pasterkamp G. Innate immune signaling in cardiac ischemia. Nat Rev Cardiol. 2011;8(5):292-300. doi: 10.1038/nrcardio.2011.38 PMID: 21448140.
39. Hubacek JA, Pit'ha J, Škodová Z, Stanečk V. C (-260) !T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction. Circulation. 1999. 11076604062628302091related:C82bZrUAuJkJ.
40. Krüger S, Graf J, Merx MW, Stickel T, Koch KC, Janssens U, et al. CD14 gene-260 C/T polymorphism is associated with chronic heart failure. European Journal of Internal Medicine. 2005;16(5):345-7. PMID: 16137548
41. Glezeva N, Voon V, Watson C, Horgan S, McDonald K, Ledwidge M, et al. Exaggerated inflammation and monocytosis associate with diastolic dysfunction in heart failure with preserved ejection fraction: evidence of M2 macrophage activation in disease pathogenesis. J Card Fail. 2015;21(2):167-77. doi: 10.1016/j.cardfail.2014.11.004 PMID: 25459685.
42. Lu W, Zhang Z, Fu C, Ma G. Intermediate monocytes lead to enhanced myocardial remodelling in STEMI patients with diabetes. Int Heart J. 2015;56(1):22-8. doi: 10.1536/ihj.14-174 PMID: 25503660.
43. Anker SD, Egerer KR, Volk HD, Kox WJ, Poole-Wilson PA, Coats AJ. Elevated soluble CD14 receptors and altered cytokines in chronic heart failure. Am J Cardiol. 1997;79(10):1426-30. PMID: 9165177.
44. Beemath A, Stein PD, Skaf E, Al Sibae MR, Alesh I. Risk of venous thromboembolism in patients hospitalized with heart failure. Am J Cardiol. 2006;98(6):793-5. doi: 10.1016/j.amjcard.2006.03.064 PMID: 16950187.
45. Badimon L, Vilahur G. Thrombosis formation on atherosclerotic lesions and plaque rupture. J Intern Med. 2014;276(6):618-32. doi: 10.1111/joim.12296 PMID: 25156650.
46. Matsuno H, Kozawa O, Yoshimi N, Akamatsu S, Hara A, Mori H, et al. Lack of alpha2-antiplasmin promotes pulmonary heart failure via overrelease of VEGF after acute myocardial infarction. Blood. 2002;100(7):2487-93. doi: 10.1182/blood-2001-12-0251 PMID: 12239160.
47. Francis RB Jr, Sandler RM, Levitan D, Feinstein EI, Massry SG, Feinstein DI. Reduced alpha-2-antiplasmin levels in the nephrotic syndrome. Nephron. 1985;39(4):325-9. PMID: 3157072.
48. Kanhai D, de Kleijn D, Kappelle L, Uiterwaal C, van der Graaf Y, Pasterkamp G, et al. Microvesicle protein levels are related to brain atrophy and cerebral white matter lesions in patients with manifest vascular disease: the SMART-MR study. Adiposity, Adipocytokines & Microvesicles. 2013:115.
49. Emmens RW, Baylan U, Juffermans LJ, Karia RV, Ylstra B, Wouters D, et al. Endogenous C1-inhibitor production and expression in the heart after acute myocardial infarction. Cardiovasc Pathol. 2015. doi: 10.1016/j.carpath.2015.09.006 PMID: 26476955.
50. Lu F, Fernandes SM, Davis AE 3rd. The effect of C1 inhibitor on myocardial ischemia and reperfusion injury. Cardiovasc Pathol. 2013;22(1):75-80. doi: 10.1016/j.carpath.2012.05.003 PMID: 22705194; PubMed Central PMCID: PMCPMC3449044.
51. Daniels LB, Maisel AS. Natriuretic peptides. J Am Coll Cardiol. 2007;50(25):2357-68. doi: 10.1016/j. jacc.2007.09.021 PMID: 18154959.
52. Baranyai T, Herczeg K, Onódi Z, Voszka I, Módos K, Marton N, et al. Isolation of Exosomes from Blood Plasma: Qualitative and Quantitative Comparison of Ultracentrifugation and Size Exclusion Chromatography Methods. PloS one. 2015;10(12):e0145686. doi: 10.1371/journal.pone.0145686 PMID: 26690353